πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

514 results for β€œVir” Clear

  1. Telaprevir

    Vertex Pharmaceuticals (Australia) Pty.

    Hepatitis C

    approved small molecule completed

    11 trials

  2. Tenofovir Alafenamide 25 MG

    The First People's Hospital of Lianyungang

    Chronic Hepatitis C

    approved small molecule active

    1 trial

  3. Tenofovir Alafenamide Tablets

    The First People's Hospital of Lianyungang

    Chronic Hepatitis b

    approved small molecule active

    1 trial

  4. Tenofovir Alafenamide fumarate 25mg Oral Tablet

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  5. Tenofovir disoproxil fumarate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  6. Trivalent live attenuated seasonal influenza vaccine

    The University of Hong Kong

    Influenza Virus Infection

    approved mab completed

    1 trial

  7. Vaccination to prevent hepatitis B virus infection

    BRIGHT MINDS BIOSCIENCES INC.

    Hepatitis B

    approved mab completed

    1 trial

  8. Vaxigrip Tetra, suspensie voor injectie in een voorgevulde spuit Quadrivalent griepvaccin (gesplitst virion, geΓ―nactiveerd), Fluenz Tetra nasal spray suspension Influenza vaccine (live attenuated, nasal)

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial

  9. Ziagen 300 mg film-coated tablets, INTELENCE 200 mg tablets, Eviplera 200 mg/25 mg/245 mg film-coated tablets, EDURANT 25 mg film-coated tablets, Telzir 700 mg film-coated tablets, TRIZIVIR 300 mg/150 mg/300 mg film-coated tablets, Delstrigo 100 mg/300 mg/245 mg film-coated tablets, Norvir 100 mg film-coated tablets, Ritonavir Accord 100 mg filmomhulde tabletten, Descovy 200 mg/10 mg film-coated tablets, REYATAZΒ 300Β mg hard capsules, REKAMBYS 600 mg prolonged-release suspension for injection, Tivicay 50 mg

    Disc Medicine

    HIV-infected

    approved small molecule active

    1 trial

  10. adefovir dipivoxil

    GlaxoSmithKline

    Hepatitis B, Chronic

    approved small molecule completed

    1 trial

  11. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  12. oral entecavir 0.5mg daily and adefovir 10mg daily for 144 weeks

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Chronic Hepatitis B

    approved small molecule active

    1 trial

  13. pegylated interferon alpha and plus ribavirin

    Hospital Authority, Hong Kong

    Chronic Hepatitis C

    approved small molecule completed

    1 trial

  14. split-virion, adjuvanted H1N1 vaccine of 7.5 ΞΌg per dose

    Sinovac Research and Development Co.,

    Influenza

    approved mab completed

    1 trial

  15. ASC09/ritonavir group

    The First People's Hospital of Lianyungang

    2019-nCoV

    small molecule terminated

    1 trial

  16. Buprenorphine/naloxone

    BRIGHT MINDS BIOSCIENCES INC.

    Human Immunodeficiency Virus

    small molecule completed

    1 trial

  17. CMV-VST

    Chongqing Precision Biotech Co., Ltd

    Cytomegalovirus Viremia

    mab active

    1 trial

  18. ET-01

    Guangzhou Virotech Pharmaceutical Co.,

    Transfusion Dependent Beta-Thalassaemia

    mab terminated

    1 trial

  19. Entecavir

    Hospital Authority, Hong Kong

    Hepatocellular Carcinoma

    small molecule completed

    1 trial

  20. Entecavir 0.5 mg

    The First People's Hospital of Lianyungang

    Hepatitis B

    small molecule active

    1 trial

  21. Favipiravir

    The First People's Hospital of Lianyungang

    COVID-19

    small molecule active

    1 trial

  22. Fuzheng 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Immune Deficiency Syndrome Virus

    small molecule active

    1 trial

  23. Fuzheng 3

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acquired Immune Deficiency Syndrome Virus

    small molecule active

    1 trial

  24. HIV self-testing among female sex workers

    United Therapeutics Europe Ltd

    Human Immunodeficiency Virus (HIV)

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources